TrialIntensive care medicine2016

The use of low-dose IV haloperidol is not associated with QTc prolongation: post hoc analysis of a randomized, placebo-controlled trial.

Matthew S Duprey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.